BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37683370)

  • 1. A comprehensive LC-UHPLC-MS/MS method for the monitoring of N-nitrosamines in lipophilic drugs: A case study with rifampicin.
    de Souza GFP; Araujo Vieira Matos MF; de Castro Aglio T; Salles AG; Rath S
    J Pharm Biomed Anal; 2023 Nov; 236():115685. PubMed ID: 37683370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.
    Kalauz A; Tiringer KV; Horváth V; Kapui I
    J Chromatogr A; 2023 Oct; 1708():464323. PubMed ID: 37696123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of LC-MS/MS Method for the Determination of 1-Methyl-4-Nitrosopiperazine (MNP) in Multicomponent Products with Rifampicin-Analytical Challenges and Degradation Studies.
    Witkowska AB; Wołczyńska A; Lis-Cieplak A; Stolarczyk EU
    Molecules; 2023 Nov; 28(21):. PubMed ID: 37959824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of genotoxic N-nitrosamines in active pharmaceutical ingredients and market authorized products in low abundance by means of liquid chromatography - tandem mass spectrometry.
    Vogel M; Norwig J
    J Pharm Biomed Anal; 2022 Sep; 219():114910. PubMed ID: 35779354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analytical Method Capable of Quantifying Eight Nitrosamine Impurities from Five Different Commercially Available Metformin Formulations with Glipizide, Glibenclamide, Gliclazide, Evogliptin, and Glimepiride by Ultra High Performance Liquid Chromatography Tripple Quadrupole Mass Spectrometry.
    Solanki R; Wadhwana P; Patel R; Gayakvad B; Kothari C; Patel C
    J Pharm Sci; 2023 May; 112(5):1268-1276. PubMed ID: 36822274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A GC-MS/MS Method for Trace Level Quantification of Six Nitrosamine Impurities (NDMA, NDEA, NEIPA, NDIPA, NDPA, and NDBA) in Commercially Used Organic Solvents: Dichloromethane, Ethyl Acetate, Toluene, and O-xylene.
    Kosuri ER; Bhanti M; Jaywant MA; Han M; Wang X; Obeng M
    J Pharm Sci; 2023 May; 112(5):1225-1230. PubMed ID: 36462706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation and optimization of a HS-SPME-assisted GC-MS/MS method for monitoring nitrosamine impurities in diverse pharmaceuticals.
    Chang SH; Ho HY; Chang CC; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
    J Pharm Biomed Anal; 2022 Nov; 221():115003. PubMed ID: 36095885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of N-nitrosodimethylamine from drug substances using solid-phase extraction-liquid chromatography-tandem mass spectrometry.
    Yamamoto E; Kan-No H; Tomita N; Ando D; Miyazaki T; Izutsu KI
    J Pharm Biomed Anal; 2022 Feb; 210():114561. PubMed ID: 34974238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of Carcinogenic Impurities of N-Nitrosamines in Sartan Pharmaceutical Products Marketed in Brazil: Development and Validation of Method Based on High-Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Monteiro MA; de Lima PC; Novotny TS; Santana DS; Lima MED; Dantas ASCL; Ferreira LODS; de Souza MN; Maranho RLDN; Ochs SM
    J Pharm Sci; 2023 May; 112(5):1305-1314. PubMed ID: 36657719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a Novel LC-MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials.
    Kartop RA; Güleli M; Faruzlu FA; Çalışkan C
    J Pharm Sci; 2024 Jun; 113(6):1597-1606. PubMed ID: 38253223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nitrosamine contamination of drugs, part 3: Quantification of 4-Methyl-1-nitrosopiperazine in rifampicin capsules by LC-MS/HRMS.
    Wohlfart J; Scherf-Clavel O; Kinzig M; Sörgel F; Holzgrabe U
    J Pharm Biomed Anal; 2021 Sep; 203():114205. PubMed ID: 34130010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of 13 nitrosamine impurities in biological medicines using salting-out liquid-liquid extraction coupled with liquid chromatography tandem mass spectrometry.
    Luo F; Liu Y; Xie Y; Hou W; Zhang L; Zhang Z
    J Pharm Biomed Anal; 2022 Sep; 218():114867. PubMed ID: 35679708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry with electron ionization for determination of N-nitrosamines in environmental water.
    Chen W; Li X; Huang H; Zhu X; Jiang X; Zhang Y; Cen K; Zhao L; Liu X; Qi S
    Chemosphere; 2017 Feb; 168():1400-1410. PubMed ID: 27923502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a sensitive LC-APCI-MS/MS method for simultaneous determination of eleven nitrosamines in valsartan and irbesartan with a simple extraction approach.
    Mavis ME; Goksu Gursu G; Ular Cagatay N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Feb; 1216():123593. PubMed ID: 36669257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Determination of N-nitrosamines in rubber products by solid phase extraction purification and ultra high performance liquid chromatography-tandem mass spectrometry].
    Chen T; Wen Y; Ou Y; Gong Z
    Se Pu; 2014 Jan; 32(1):89-94. PubMed ID: 24783874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Sensitive Headspace Gas Chromatography-Mass Spectrometry Method for the Simultaneous Determination of Nitrosamines in Losartan Active Pharmaceutical Ingredients.
    Wichitnithad W; Sudtanon O; Srisunak P; Cheewatanakornkool K; Nantaphol S; Rojsitthisak P
    ACS Omega; 2021 Apr; 6(16):11048-11058. PubMed ID: 34056258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a Sensitive Screening Method for Simultaneous Determination of Nine Genotoxic Nitrosamines in Active Pharmaceutical Ingredients by GC-MS.
    Witkowska AB; Giebułtowicz J; Dąbrowska M; Stolarczyk EU
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multi-analyte LC-MS/MS method for screening and quantification of nitrosamines in sartans.
    Chang SH; Chang CC; Wang LJ; Chen WC; Fan SY; Zang CZ; Hsu YH; Lin MC; Tseng SH; Wang DY
    J Food Drug Anal; 2020 Jun; 28(2):292-301. PubMed ID: 35696119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Method for trace determination of N-nitrosamines impurities in metronidazole benzoate using high-performance liquid chromatography coupled with atmospheric-pressure chemical ionization tandem mass spectrometry.
    Yin M; Hu Y; Fan H; Wang Q; Wang M; Wang W; Shi C
    J Sep Sci; 2023 Mar; 46(5):e2200225. PubMed ID: 36562102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.
    Wichitnithad W; Nantaphol S; Noppakhunsomboon K; Rojsitthisak P
    Saudi Pharm J; 2023 Feb; 31(2):295-311. PubMed ID: 36942272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.